Roivant Sciences (NASDAQ:ROIV) Given “Overweight” Rating at Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a report issued on Tuesday morning, Benzinga reports. Several other analysts also recently weighed in on ROIV. HC Wainwright reaffirmed a buy rating and set a $18.00 price target on shares of Roivant Sciences in a research note on […]

Leave a Reply

Your email address will not be published.

Previous post Keefe, Bruyette & Woods Reaffirms “Market Perform” Rating for Blackstone Mortgage Trust (NYSE:BXMT)
Next post Unison pushes for four-day work week for NHS staff and police